Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Wang

Podiatrist, Primary Podiatric Medicine Los Angeles, CA Doctor of Podiatric Medicine

NPI 1588678130 CMS profile 207469

8436 W 3Rd St Ste 800, Los Angeles, CA 90048

Open in the dashboard

General payments

$250,236

234 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James Wang of Los Angeles, CA is reported in the CMS Open Payments database as having received $250,236 across 234 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Podiatrist, Primary Podiatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,392 14
2024 General $25,279 34
2023 General $15,430 12
2022 General $45,311 49
2021 General $59,110 52
2020 General $27,344 9
2019 General $70,369 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Wang
  • Podiatrist, Primary Podiatric Medicine median
  • Middle half of Podiatrist, Primary Podiatric Medicine
  • National median

In program year 2025, general payments to James Wang were reported at $7,392. Among 368 Podiatrist, Primary Podiatric Medicine profiles paid that year, the median was $232 and the middle half received between $88 and $586.

Show as a table
Year James Wang Podiatrist, Primary Podiatric Medicine median Middle half National median
2019 $70,369 $166 $51–$513 $163
2020 $27,344 $108 $33–$249 $114
2021 $59,110 $147 $52–$377 $132
2022 $45,311 $188 $66–$551 $149
2023 $15,430 $195 $70–$509 $160
2024 $25,279 $209 $59–$508 $164
2025 $7,392 $232 $88–$586 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Orthofix Medical, Inc. $137,543 186 payments
  2. AMDT Holdings, Inc. $56,178 7 payments
  3. NuVasive, Inc. $48,276 23 payments
  4. Arthrex, Inc. $7,088 5 payments
  5. WishBone Medical Inc. $600 2 payments
  6. Pacira Pharmaceuticals Incorporated $163 1 payment
  7. DePuy Synthes Sales Inc. $152 5 payments
  8. E.R. Squibb & Sons, L.L.C. $150 1 payment
  9. Bioventus LLC $24 1 payment
  10. Linvatec Corporation $23 1 payment
  11. Other $39 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $167,068 43 payments
  2. Royalty or License $63,074 10 payments
  3. Travel and Lodging $15,558 82 payments
  4. Food and Beverage $4,373 98 payments
  5. Honoraria $163 1 payment
Products named General payments · program years 2019–2025
  1. JUNIORTHO PLATING SYSTEM $70,604 35 payments
  2. Minirail System $22,116 9 payments
  3. TrueLok $20,315 91 payments
  4. AMDT Mini-Rail Mini-Rail External Fixation $10,820 1 payment
  5. ISKD (Intramedullary Skeletal Kinetic Distractor) $7,685 4 payments
  6. Gotfried PC.C.P. $7,215 2 payments
  7. GALAXY Wrist $7,215 2 payments
  8. Guided Growth System $7,200 1 payment
  9. LRS Pediatric $7,200 1 payment
  10. AMDT Mini-Rail AMDT Min-Rail $7,088 5 payments
  11. Other $88,671 188 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 15 billing codes

Paid by Medicare

$8,007

Medicare's payments for the services billed

Medicare patients

36

Average age 76

Services billed

85

22 women, 14 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 72%
Chronic kidney disease 36%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

234 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Primary Podiatric Medicine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record